ENTITY

Genocea Biosciences (GNCA US)

Health CareUnited States
Genocea Biosciences, Inc. operates as a biotechnology company. The Company develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. Genocea Biosciences uses priority identification platform to build a pipeline of immunotherapies for genital herpes and neoantigen cancer vaccine.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x